Cargando…
PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429465/ http://dx.doi.org/10.1097/01.HS9.0000975640.82589.03 |
| _version_ | 1785090720013484032 |
|---|---|
| author | Mascarenhas, John He, Lei Saab, Rabih Gabrail, Nashat Kirito, Keita Brackman, Deanna Innocenti, Federico |
| author_facet | Mascarenhas, John He, Lei Saab, Rabih Gabrail, Nashat Kirito, Keita Brackman, Deanna Innocenti, Federico |
| author_sort | Mascarenhas, John |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429465 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104294652023-08-17 PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY Mascarenhas, John He, Lei Saab, Rabih Gabrail, Nashat Kirito, Keita Brackman, Deanna Innocenti, Federico Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429465/ http://dx.doi.org/10.1097/01.HS9.0000975640.82589.03 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Mascarenhas, John He, Lei Saab, Rabih Gabrail, Nashat Kirito, Keita Brackman, Deanna Innocenti, Federico PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title | PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title_full | PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title_fullStr | PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title_full_unstemmed | PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title_short | PB2224: ABBV-744 ALONE OR IN COMBINATION WITH RUXOLITINIB OR NAVITOCLAX IN PATIENTS WITH MYELOFIBROSIS: A PHASE 1B STUDY |
| title_sort | pb2224: abbv-744 alone or in combination with ruxolitinib or navitoclax in patients with myelofibrosis: a phase 1b study |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429465/ http://dx.doi.org/10.1097/01.HS9.0000975640.82589.03 |
| work_keys_str_mv | AT mascarenhasjohn pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT helei pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT saabrabih pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT gabrailnashat pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT kiritokeita pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT brackmandeanna pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy AT innocentifederico pb2224abbv744aloneorincombinationwithruxolitinibornavitoclaxinpatientswithmyelofibrosisaphase1bstudy |